- C49.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM C49.3 became effective on October 1, 2022.
- This is the American ICD-10-CM version of C49.3 – other international versions of ICD-10 C49.3 may differ.
ICD-10-CM C49.3 is grouped within Diagnostic Related Group(s):
- 542 Pathological fractures and musculoskeletal and connective tissue malignancy with mcc
- 543 Pathological fractures and musculoskeletal and connective tissue malignancy with cc
- 544 Pathological fractures and musculoskeletal and connective tissue malignancy without cc/mcc
Applicable To
- Malignant neoplasm of axilla
- Malignant neoplasm of diaphragm
- Malignant neoplasm of great vessels
Type 1 Excludes
- malignant neoplasm of breast (C50.-)
- malignant neoplasm of heart (C38.0)
- malignant neoplasm of mediastinum (C38.1-C38.3)
- malignant neoplasm of thymus (C37)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to C49.3: